CA-AMERICAN-EXPRESS
31.12.2022 14:01:42 CET | Business Wire | Press release
Today American Express (NYSE:AXP) reopened the newly expanded Centurion Lounge at the San Francisco International Airport (SFO). At 16,000 square feet the lounge is now nearly double in size and features more seating, an additional bar with specialty wine flights curated by sommelier and Centurion Lounge Wine Director Anthony Giglio, and a new menu from San Francisco’s Liholiho Yacht Club Executive Chef Ravi Kapur.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221231005003/en/
American Express Opens 16,000 Square Foot Centurion Lounge at San Francisco International Airport (Photo: Business Wire)
“We’re excited to head into the new year with the opening of our Centurion Lounge at San Francisco International Airport,” stated Pablo Rivero, Vice President & General Manager, Global Lounge Experiences. “With exceptional food, wine and art inspired by Northern California, this well-appointed lounge is designed to leave Card Members feeling refreshed and ready for their travels.”
The Centurion Lounge at SFO will now have more space for eligible Card Members to enjoy, including two wine bars and café areas, additional restrooms, private phone rooms, several private workspaces, and more. The lounge is located in Terminal 3 on the mezzanine level.
LOCALLY SOURCED WINE1
The lounge will feature a new bar where guests can enjoy specialty wine flights highlighting four regional wines curated by renowned wine authority Anthony Giglio. The new bar complements the existing wine wall where guests can sample wines from across California. The wine flights will rotate seasonally, starting today with a Sonoma Chardonnay flight and a Napa Valley Cabernet Sauvignon flight:
Sonoma Chardonnay Flight
- Gundlach Bundschu Sonoma Coast Chardonnay 2020
- Head High Sonoma County Chardonnay 2021
- Sonoma Cutrer Les Pierres Sonoma Valley Chardonnay 2019
- Walt Sonoma Coast Chardonnay 2019
Napa Cabernet Sauvignon Flight
- Emblem Napa Valley Cabernet Sauvignon 2019
- Miner Emily's Cuvee Napa Valley Cabernet Sauvignon 2018
- The Critic Napa Valley Cabernet Sauvignon 2019
- Twenty Rows Napa Valley Reserve Cabernet Sauvignon 2020
“As San Francisco is globally known for its world-class wine, the wine menu in the Centurion Lounge at San Francisco International Airport is fully dedicated to highlighting local California grapes,” said Anthony Giglio, sommelier and Centurion Lounge Wine Director. “For our first-ever wine flight experience, I’m thrilled to feature two of America’s most famous and established wine regions - Sonoma and Napa Valley.”
ELEVATED DINING AND DESIGN
The lounge will offer a new seasonal menu that celebrates Bay Area purveyors from Liholiho Yacht Club Executive Chef Ravi Kapur. The Hawaiian-born, James Beard Award-nominated chef will continue to bring his unique flair to the Centurion Lounge at SFO with dishes inspired by his lineage and family memories including, Kochujang marinated chicken thighs, wild rice and coconut soup, and black vinegar and honey glazed baby carrots.
Consumers appreciate premium dining options when traveling through airport lounges. A recent Amex Trendex* survey found that a majority of respondents (64%) said that premium food and beverage offerings are their favorite parts of airport lounges.
The lounge will showcase two custom floor-to-ceiling wallcoverings by abstract artist Tracie Cheng, and new interior design that takes cues from the local vineyards, landscape, and the iconic San Francisco fog to give guests a sense of relaxation.
UNPARALLELED ACCESS
With more lounge options than any other credit card issuer on the market and the only credit card issuer with a proprietary lounge at SFO, the American Express Global Lounge Collection™ is just one of the many ways American Express supports Card Members through their travels. American Express continues to enhance the Centurion Lounge network through new locations and expanding existing lounges. American Express has announced plans to open new lounge locations at the Reagan National Airport (DCA) in Washington, D.C. and Hartsfield-Jackson Atlanta Airport (ATL) in 2023 and 2024 respectively.
*AMEX TRENDEX METHODOLOGY
This Amex Trendex online poll was conducted between November 4th – November 7th, 2022, among a sample of 2000 Adults with an HHI> 70k+ who travel by plane at least once a year. The interviews were conducted online. Results from the full survey have a margin of error of plus or minus 2 percentage points
ABOUT AMERICAN EXPRESS
American Express is a globally integrated payments company, providing customers with access to products, insights and experiences that enrich lives and build business success. Learn more at americanexpress.com and connect with us on facebook.com/americanexpress, instagram.com/americanexpress, linkedin.com/company/american-express, twitter.com/americanexpress, and youtube.com/americanexpress.
Key links to products, services and corporate sustainability information: personal cards, business cards and services, travel services, gift cards, prepaid cards, merchant services, Accertify, Kabbage, Resy, corporate card, business travel, diversity and inclusion, corporate sustainability and Environmental, Social, and Governance reports.
ABOUT THE CENTURION LOUNGE
The Centurion Lounge is the signature lounge program within the broader American Express Global Lounge Collection, which includes access to American Express Centurion Lounges, international American Express lounges, Delta Sky Club® for Card Members flying on Delta, Priority Pass™ Select Lounges upon enrollment, Airspace Lounges, MAG U.S. Escape Lounges and Plaza Premium Lounges--a total of more than 1,400 lounges across 140 countries and counting.
Eligible Card Members can find a lounge at the Global Lounge Collection website or by using the American Express® App. They can also check into select Centurion Lounges through the mobile check-in tool within the American Express® App.
ABOUT SAN FRANCISCO INTERNATIONAL AIRPORT
SFO is excited to welcome travelers back to the skies with an airport experience featuring seamless access, thoughtful amenities, sustainable design and inspiring artwork and exhibits.
For up-to-the-minute departure and arrival information, airport maps and details on shopping, dining, cultural exhibitions, ground transportation and more, visit www.flysfo.com. Follow us on twitter.com/flysfo and facebook.com/flysfo.
Source: American Express Company
Location: U.S.
1 Must be of legal age to consume alcoholic beverages. Please drink responsibly.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221231005003/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom